Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

ARTreat · Multi-level patient-specific artery and atherogenesis model\nfor outcome prediction, decision support treatment, and\nvirtual hand-on training

FP7Status: CLOSED1 September 200831 August 2013EU funding €7,001,768

ARTreat targets at providing a patient-specific computational model of the cardiovascular system, used to improve the quality of prediction for the atherosclerosis progression and propagation into life-threatening events that need to be treated accordingly. ARTreat will provide a three-level patient model describing the 3d arterial tree anatomy, the patient-specific blood flow and blood particle dynamics and the biological processes that lead to the creation and progression of atherosclerotic plaques. ARTreat will apply the developed patient-specific model on two main applications: the clinical decision support and the training. ARTreat will produce two decision support tools to assist clinical cardiologists into providing personalized treatment selection and real-time, on- the-fly advice during invasive interventions, such stent positioning. The aim is to minimize future therapy costs, by providing higher than even possible personalized treatment support. The same patient-specific model will also be used to develop a real-case simulator training, which will support realistic hands-on skill development training to clinical cardiologists. Finally, ARTreat is coupled with advanced clinical support tools for plaque characterization, and the discovery of new knowledge; associations among heterogeneous data, that can improve the predictive power of the patient-model. It thus supports the medical expert into programming the accumulated knowledge into the existing model and generating an adaptive patient-specific computational tool. Key market players AGFA and SORIN will exploit the ARTreat applications to provide new sophisticated solutions to their product range, while all academic and ITcompany partners will accumulate significant experience on the new generation patient-specific healthcare services.

Consortium · 23 organisations

coordinator

CONSIGLIO NAZIONALE DELLE RICERCHE

IT · €1,372,942

participant

ATCOM INTERNET & MULTIMEDIA AE

EL

participant

SAS SOFTWARE LIMITED

UK

participant

LANZA & THOMPSON INFORMATION TECHNOLOGY SRL

IT

participant

ASD ADVANCED SIMULATION AND DESIGN GMBH

DE · €532,818

participant

UNIVERSITA DEGLI STUDI DI PARMA

IT · €196,736

participant

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE

UK · €463,520

participant

LANZA & THOMPSON SERVICE SRL

IT · €344,392

participant

COMPUTER SHARING BUCURESTI SRL

RO · €411,628

participant

UNIVERZITET U KRAGUJEVCU

RS · €511,298

participant

TECHNOLOGICA EOOD

BG

participant

INTERCON SP. Z O.O.

PL · €86,934

participant

IDRYMA TECHNOLOGIAS KAI EREVNAS

EL · €1,082,110

participant

EURO (PMS) LIMITED

UK

participant

TECMIC-TECNOLOGIAS DE MICROELECTRONICA SA

PT

participant

AGFA HEALTHCARE N.V.

BE

participant

SORIN BIOMEDICA CARDIO S.R.L.

IT · €4,909

participant

D.D. SYNERGY HELLAS ANONYMI EMPORIKI ETAIREIA PAROCHIS YPIRESION PLIROFORIKIS

EL · €1,039,394

participant

TechnoLogica EAD

BG · €525,567

participant

Université Paris Descartes

FR · €403,540

participant

WORLD MATCH LIMITED

MT

participant

B. BRAUN MELSUNGEN AG

DE · €25,980

participant

SWORD TECHNOLOGIES SA

LU

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.